COVID-19 VACCINE
The best chance for ending the pandemic is vaccines to prevent coronavirus disease 2019 (COVID-19). Pressure, redness, or swelling where the shot was administered, fever, weakness, headache, muscle pain, chills, joint pain, nausea and vomiting, feeling unwell, and swollen lymph nodes are all mild side effects that may occur after the first or second dose of the COVID-19 vaccine. Some people may have been concerned about these side effects, which is why they are hesitant to get the vaccine. Others can consider routine vaccines but be wary of the COVID-19 vaccine because it is new and was developed quickly. Others are concerned about efficacy, while others are concerned about protection. Scientists tested the vaccine on human volunteers after it was created. While these early trials have shown that the vaccine is safe and efficient, much remains unclear, including how long the vaccine would be effective, if it will function against new strains of the virus, and whether or not anyone who has been vaccinated will still transmit the disease to others.
Every year, vaccines save millions of lives. Vaccines function by teaching and educating the immune system's natural defenses to identify and combat the viruses and bacteria they attack. Vaccine skepticism is on the rise, and it can have significant implications. People may be hesitant to consider the vaccine due to concerns about safety, fear of side effects, and misconceptions about COVID-19. The best ways to address vaccine mistrust are education, openness, and the fostering of vaccine acceptance by healthcare workers and community leaders.
Reference(s) :
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines
https://doh.gov.ph/faqs/vaccines
Image(s) retrieved at:
https://blogs.adb.org/blog/hunt-covid-19-vaccine
https://www.clinicaltrialsarena.com/analysis/covid-19-vaccine-mixing-the-good-the-bad-and-the-uncertain/?utm_source=Army%20Technology&utm_medium=website&utm_campaign=Must%20Read&utm_content=Image
https://www.paho.org/en/news/31-1-2021-countries-americas-notified-first-covid-19-vaccine-allocations-through-covax
Comments
Post a Comment